Related Experiment Video
Updated: Feb 9, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
BRCA1/2 testing: therapeutic implications for breast cancer management
Nadine M Tung1,2, Judy E Garber3,4
1Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA. ntung@bidmc.harvard.edu.
Germline BRCA1/2 mutation testing is crucial for breast cancer risk and treatment selection. BRCA status predicts response to platinum chemotherapy and PARP inhibitors, expanding therapeutic options for patients.
Area of Science:
- Oncology
- Genetics
- Pharmacology
Background:
- Germline BRCA1/2 mutations are established predictors of breast cancer risk.
- BRCA1/2 status is increasingly recognized for its role in guiding therapy selection for diagnosed breast cancer patients.
Purpose of the Study:
- To review current preclinical and clinical research on treating BRCA-associated breast cancer.
- To discuss strategies for identifying additional breast cancer patients who may benefit from platinum or PARP inhibitor therapies.
Main Methods:
- Summarizing recent and ongoing preclinical and clinical studies.
- Analyzing the predictive role of BRCA status in treatment response.
- Investigating potential biomarkers for therapy response.
Main Results:
- BRCA1/2 mutation status predicts responsiveness to platinum-based chemotherapy and PARP inhibitors.
- PARP inhibitors, such as olaparib, show promising progression-free survival in BRCA1/2-mutated breast cancer.
- Platinum salts exhibit differential activity in BRCA-mutated versus non-mutated breast cancer.
Conclusions:
- BRCA1/2 mutation testing is vital for optimizing treatment strategies in specific breast cancer subsets.
- Identifying patients responsive to platinum and PARP inhibitors can expand treatment options beyond standard chemotherapy.
- Further research is needed to develop reliable scoring systems for homologous recombination repair defects to guide clinical decisions.
Related Concept Videos
Therapeutic Index
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Microorganisms in Medicine and Therapeutics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Tonsillitis II: Management

